Accueil>>Signaling Pathways>> Neuroscience>> Amyloid β>>Tramiprosate

Tramiprosate (Synonyms: Homotaurine, NC 531, NC 758, NSC 77071, 3-Sulfopropylamine)

Catalog No.GC17910

Tramiprosate (homotaurine), un acide aminé naturel actif par voie orale et pénétrant dans le cerveau présent dans diverses espèces d'algues marines rouges. Le tramiprosate se lie À l'Aβ soluble et maintient l'Aβ sous une forme non fibrillaire. Le tramiprosate est également un analogue du GABA et possède des effets neuroprotecteurs, anticonvulsifs et antihypertenseurs.

Products are for research use only. Not for human use. We do not sell to patients.

Tramiprosate Chemical Structure

Cas No.: 3687-18-1

Taille Prix Stock Qté
10mM (in 1mL DMSO)
34,00 $US
En stock
50mg
46,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Tramiprosate is a small, orally-administered compound that binds to soluble Aβ and reduces amyloid aggregation and subsequent depositiontarget: AβIn vitro: Tramiprosate provides neuroprotection against Aβ-induced neurotoxicity in neuronal and mouse organotypic hippocampal cultures, and reverses Aβ-induced long-term potentiation (LTP) inhibition in rat hippocampus, in part, through activation of β-aminobutyric acid A (GABA-A) receptors. Tramiprosate dose-dependently provides neuroprotection against ischemic stroke.In vivo: Tramiprosate produced dose-dependent reductions of Aβ in the brain of transgenic mice (hAPP-TgCRND8). Clinical studies show that tramiprosate was safe and tolerable. In mild-to-moderate AD patients tramiprosate also reduced Aβ42 levels in CSF.The reference for animal administration is 50 mg/kg.

References:
[1]. Wu S et al. Tramiprosate protects neurons against ischemic stroke by disrupting the interaction between PSD95 and nNOS. Neuropharmacology. 2014 Aug;83:107-17.
[2]. Aisen PS et al. Tramiprosate in mild-to-moderate Alzheimer's disease - a randomized, double-blind, placebo-controlled, multi-centre study (the Alphase Study). Arch Med Sci. 2011 Feb;7(1):102-11.

Avis

Review for Tramiprosate

Average Rating: 5 ★★★★★ (Based on Reviews and 9 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Tramiprosate

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.